Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chitosan-Modified Gold Nanoparticle-Based Electrochemical Immunosensor for C-Reactive Protein Detection.

Bioengineering (Basel, Switzerland)·2026
Same author

Repurposing the antispasmodic drug pinaverium bromide as a novel antifungal agent and synergist against <i>Candida albicans</i>.

Virulence·2026
Same author

Hybrid and conjugated antimicrobial peptides: new tactics to counter bacterial resistance.

Frontiers in microbiology·2026
Same author

Rv2647-Mediated NLRP3 Ubiquitination Inhibits Macrophage Pyroptosis and Promotes <i>Mycobacterium tuberculosis</i> Survival.

ACS infectious diseases·2025
Same author

Immunogenicity-Guided Design of an Acinetobacter baumanii Vaccine.

European journal of immunology·2025
Same author

Graphene-based nanomaterials: mechanisms and potentials in the fight against multidrug resistant bacterial infections: a review.

RSC advances·2025

Related Experiment Video

Updated: Aug 12, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

684

Subunit vaccines for Acinetobacter baumannii.

Ning Yang1, Xiao Jin1, Chenghua Zhu1

  • 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Frontiers in Immunology
|January 30, 2023
PubMed
Summary
This summary is machine-generated.

Developing effective subunit vaccines against Acinetobacter baumannii is crucial for combating hospital infections. Optimizing adjuvants and immunization methods is key to enhancing vaccine efficacy and overcoming challenges like weak immunogenicity.

Keywords:
Acinetobacter baumanniiadjuvantimmunityimmunization routesubunit vaccine

More Related Videos

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
07:59

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System

Published on: April 25, 2025

434
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.5K

Related Experiment Videos

Last Updated: Aug 12, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

684
Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
07:59

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System

Published on: April 25, 2025

434
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.5K

Area of Science:

  • Bacteriology
  • Immunology
  • Vaccinology

Background:

  • Acinetobacter baumannii is a significant hospital-acquired pathogen.
  • Increasing multidrug-resistant strains pose a global health challenge.
  • Vaccines are vital for controlling A. baumannii infections.

Purpose of the Study:

  • To review current research on Acinetobacter baumannii subunit vaccines.
  • To identify challenges and potential solutions for A. baumannii vaccine development.
  • To guide future research in A. baumannii vaccine strategies.

Main Methods:

  • Review of existing literature on A. baumannii subunit vaccines.
  • Analysis of factors affecting subunit vaccine efficacy (adjuvants, delivery vehicles, immunization routes).
  • Discussion of challenges such as in vivo degradation and weak immunogenicity.

Main Results:

  • Subunit vaccines offer advantages in purity, safety, and targeted immune response.
  • No A. baumannii subunit vaccine candidates have reached clinical trials.
  • Adjuvants and delivery vehicles can improve immunogenicity and stability.
  • Appropriate immunization routes enhance vaccine effectiveness.

Conclusions:

  • Optimizing adjuvants and immunization methods is critical for successful A. baumannii subunit vaccine development.
  • Further research is needed to overcome current limitations and advance vaccine candidates.
  • Effective vaccines are essential to combat the growing threat of multidrug-resistant A. baumannii.